235 related articles for article (PubMed ID: 36980828)
41. Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines.
Robson H; Meyer S; Shalet SM; Anderson E; Roberts S; Eden OB
Med Pediatr Oncol; 2002 Dec; 39(6):573-80. PubMed ID: 12376980
[TBL] [Abstract][Full Text] [Related]
42. Biological features of tissue and bone sarcomas investigated using an in vitro model of clonal selection.
Avdonkina NA; Danilova AB; Misyurin VA; Prosekina EA; Girdyuk DV; Emelyanova NV; Nekhaeva TL; Gafton GI; Baldueva IA
Pathol Res Pract; 2021 Jan; 217():153214. PubMed ID: 33290900
[TBL] [Abstract][Full Text] [Related]
43. MiR-34c inhibits osteosarcoma metastasis and chemoresistance.
Xu M; Jin H; Xu CX; Bi WZ; Wang Y
Med Oncol; 2014 Jun; 31(6):972. PubMed ID: 24802328
[TBL] [Abstract][Full Text] [Related]
44. Hypoxia promotes chemotherapy resistance by down-regulating SKA1 gene expression in human osteosarcoma.
Ma Q; Zhang Y; Liu T; Jiang K; Wen Y; Fan Q; Qiu X
Cancer Biol Ther; 2017 Mar; 18(3):177-185. PubMed ID: 28278080
[TBL] [Abstract][Full Text] [Related]
45. miR-223/Hsp70/JNK/JUN/miR-223 feedback loop modulates the chemoresistance of osteosarcoma to cisplatin.
Tang Q; Yuan Q; Li H; Wang W; Xie G; Zhu K; Li D
Biochem Biophys Res Commun; 2018 Mar; 497(3):827-834. PubMed ID: 29432736
[TBL] [Abstract][Full Text] [Related]
46. Addressing Doxorubicin Resistance in Bone Sarcomas Using Novel Drug-Resistant Models.
Gallego B; Murillo D; Rey V; Huergo C; Estupiñán Ó; Rodríguez A; Tornín J; Rodríguez R
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742867
[TBL] [Abstract][Full Text] [Related]
47. Growth arrest-specific 5 lncRNA as a valuable biomarker of chemoresistance in osteosarcoma.
Polvani S; Martignano F; Scoccianti G; Pasqui A; Palomba AR; Conticello S; Galli A; Palchetti I; Caporalini C; Antonuzzo L; Campanacci DA; Pillozzi S
Anticancer Drugs; 2022 Mar; 33(3):278-285. PubMed ID: 35045526
[TBL] [Abstract][Full Text] [Related]
48. miR-146b-5p promotes invasion and metastasis contributing to chemoresistance in osteosarcoma by targeting zinc and ring finger 3.
Xu E; Zhao J; Ma J; Wang C; Zhang C; Jiang H; Cheng J; Gao R; Zhou X
Oncol Rep; 2016 Jan; 35(1):275-83. PubMed ID: 26549292
[TBL] [Abstract][Full Text] [Related]
49. Podocalyxin promotes cisplatin chemoresistance in osteosarcoma cells through phosphatidylinositide 3-kinase signaling.
Huang Z; Huang Y; He H; Ni J
Mol Med Rep; 2015 Sep; 12(3):3916-3922. PubMed ID: 26017117
[TBL] [Abstract][Full Text] [Related]
50. Long non-coding RNA LUCAT1 modulates methotrexate resistance in osteosarcoma via miR-200c/ABCB1 axis.
Han Z; Shi L
Biochem Biophys Res Commun; 2018 Jan; 495(1):947-953. PubMed ID: 29170124
[TBL] [Abstract][Full Text] [Related]
51. Mesenchymal stem cells promote osteosarcoma cell survival and drug resistance through activation of STAT3.
Tu B; Zhu J; Liu S; Wang L; Fan Q; Hao Y; Fan C; Tang TT
Oncotarget; 2016 Jul; 7(30):48296-48308. PubMed ID: 27340780
[TBL] [Abstract][Full Text] [Related]
52. Screening circular RNA related to chemotherapeutic resistance in osteosarcoma by RNA sequencing.
Kun-Peng Z; Xiao-Long M; Lei Z; Chun-Lin Z; Jian-Ping H; Tai-Cheng Z
Epigenomics; 2018 Oct; 10(10):1327-1346. PubMed ID: 30191736
[TBL] [Abstract][Full Text] [Related]
53. Gemcitabine-induced epithelial-mesenchymal transition-like changes sustain chemoresistance of pancreatic cancer cells of mesenchymal-like phenotype.
El Amrani M; Corfiotti F; Corvaisier M; Vasseur R; Fulbert M; Skrzypczyk C; Deshorgues AC; Gnemmi V; Tulasne D; Lahdaoui F; Vincent A; Pruvot FR; Van Seuningen I; Huet G; Truant S
Mol Carcinog; 2019 Nov; 58(11):1985-1997. PubMed ID: 31373074
[TBL] [Abstract][Full Text] [Related]
54. CircRNA PVT1 promotes proliferation and chemoresistance of osteosarcoma cells via the miR-24-3p/KLF8 axis.
Wang B; Yan L; Shi W; Xie H; Chen R; Shao Y; Liang W
Int J Clin Oncol; 2022 Apr; 27(4):811-822. PubMed ID: 35171359
[TBL] [Abstract][Full Text] [Related]
55. Pre-clinical evaluation of proteasome inhibitors for canine and human osteosarcoma.
Patatsos K; Shekhar TM; Hawkins CJ
Vet Comp Oncol; 2018 Dec; 16(4):544-553. PubMed ID: 29998615
[TBL] [Abstract][Full Text] [Related]
56. Long noncoding RNA OIP5-AS1 mediates resistance to doxorubicin by regulating miR-137-3p/PTN axis in osteosarcoma.
Sun X; Tian C; Zhang H; Han K; Zhou M; Gan Z; Zhu H; Min D
Biomed Pharmacother; 2020 Aug; 128():110201. PubMed ID: 32460190
[TBL] [Abstract][Full Text] [Related]
57. miR-340 alleviates chemoresistance of osteosarcoma cells by targeting ZEB1.
Yan H; Zhang B; Fang C; Chen L
Anticancer Drugs; 2018 Jun; 29(5):440-448. PubMed ID: 29494357
[TBL] [Abstract][Full Text] [Related]
58. miR-22 targets the 3' UTR of HMGB1 and inhibits the HMGB1-associated autophagy in osteosarcoma cells during chemotherapy.
Li X; Wang S; Chen Y; Liu G; Yang X
Tumour Biol; 2014 Jun; 35(6):6021-8. PubMed ID: 24609901
[TBL] [Abstract][Full Text] [Related]
59. Long non-coding RNA LINC00161 sensitises osteosarcoma cells to cisplatin-induced apoptosis by regulating the miR-645-IFIT2 axis.
Wang Y; Zhang L; Zheng X; Zhong W; Tian X; Yin B; Tian K; Zhang W
Cancer Lett; 2016 Nov; 382(2):137-146. PubMed ID: 27609068
[TBL] [Abstract][Full Text] [Related]
60. Small Nucleolar RNAs Determine Resistance to Doxorubicin in Human Osteosarcoma.
Godel M; Morena D; Ananthanarayanan P; Buondonno I; Ferrero G; Hattinger CM; Di Nicolantonio F; Serra M; Taulli R; Cordero F; Riganti C; Kopecka J
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
